SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-022335
Filing Date
2024-05-09
Accepted
2024-05-09 17:16:40
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 ginkgobio-sx3.htm S-3 283423
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 29179
3 EX-5.1 exhibit51-sx3.htm EX-5.1 7787
4 EX-23.1 exhibit231-sx3.htm EX-23.1 2508
5 ginkgobiologoa.jpg GRAPHIC 6914
6 image_0a.jpg GRAPHIC 58735
  Complete submission text file 0001628280-24-022335.txt   414727
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279280 | Film No.: 24931931
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)